SureTrader
Home > Boards > US Listed > Medical - Drugs > Galena Biopharma (GALE)

I sold my last shares of Gale this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 121
Posts 10,454
Boards Moderated 3
Alias Born 01/06/10
160x600 placeholder
SELLAS Life Sciences to Present at Two Upcoming February Investor Conferences GlobeNewswire Inc. - 2/6/2018 8:30:00 AM
Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors GlobeNewswire Inc. - 2/1/2018 4:01:00 PM
SELLAS Life Sciences Group to Present Complete Phase 2 Correlative Results for its Lead Cancer Immunotherapy Candidate, galin... GlobeNewswire Inc. - 1/24/2018 8:55:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2017 5:13:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2017 5:12:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2017 5:12:19 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:09:39 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:09:14 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:08:20 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:06:34 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:05:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:04:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:03:28 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 5:02:11 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/29/2017 4:59:43 PM
SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma GlobeNewswire Inc. - 12/29/2017 4:46:00 PM
Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Sto... GlobeNewswire Inc. - 12/29/2017 9:25:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/15/2017 11:53:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/14/2017 5:31:33 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/14/2017 5:29:19 PM
Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote GlobeNewswire Inc. - 12/14/2017 5:03:38 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/11/2017 5:27:06 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/8/2017 5:27:44 PM
Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017 GlobeNewswire Inc. - 12/8/2017 2:50:37 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/6/2017 2:27:11 PM
noretreat   Friday, 02/14/14 10:25:43 AM
Re: None
Post # of 10488 
I sold my last shares of Gale this morning, after lightening up by 90% over the previous month. It looks like these issues aren't going to go away quickly, and management does not seem to want to address them. Riding the run-up was nice.

Does not look like the CLDX of 2014 anymore, but who knows? There should be a bounce here a some point.


Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist